Manchester University Touts Pharma Growth
Manchester University in northern Indiana launched the country's first pharmacogenomics program in 2016 and just five years later, the program has grown tenfold. The master's degree program, which began with just eight students, involves the study of the influence of a person's genetics in how they respond to medications. Dr. David Kisor, director of pharmacogenomics at Manchester, says the program has found global appeal and led to more programs being developed across the country.... Read More